Nautilus Biotechnology(NAUT) - 2021 Q4 - Earnings Call Presentation

In C Delivering on the Promise of the Proteome FEBRUARY, 2022 Safe harbor This presentation and the accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding the size and growth of the protein analysis market; Nautilus Biotechnology's anticipated total addressable market; the performance of Nautilus Biotechnology's proteomics technology platform; Nautilus Biotechnology's business ...